First Clinical Evaluation of TURKOVAC Made

Scientific Committee Member Prof. Dr. Ateş Kara examined the clinical evaluation data of the domestic coronavirus vaccine TURKOVAC. Dr. Kara stated that the clinical analysis results of the TURKOVAC vaccine are quite positive.

Health Minister Fahrettin Koca had announced that the application for emergency use approval of TURKOVAC, the domestic vaccine developed by Turkey, was made about 3 weeks ago. While the evaluation process of the vaccine continues, President of the Turkey Vaccine Institute and Member of the Coronavirus Scientific Committee Prof. Dr. Ateş Kara, the local vaccine clinical analysis results evaluated.

prof. Dr. Ateş Kara, according to the preliminary data obtained regarding the vaccine, COVID-19 among people who have been vaccinated with TURKOVAC so far. not having a heavy expressed. Dr. Kara also determined the antibody levels at the reminder dose of the native vaccine. raising quickly reported.

“The results are quite positive”

Ministry of Health Coronavirus Scientific Committee Member Prof. Dr. Results of clinical analysis of Ateş Kara native coronavirus vaccine TURKOVAC quite positive stated that. Dr. Evaluation process of Kara TURKOVAC “In order to observe the efficacy of the domestic vaccine in the clinical analysis, TURKOVAC was administered to one group and a currently used vaccine was administered to the other group. According to the data obtained as a result of the observation, the difference between the individuals in both groups seriously ill, to hospital or to intensive care did not sleep. Considering the number of people who are positive for COVID-19, it is seen that those who have the TURKOVAC vaccine more advantageous appeared to be.” told in his words. Professor Kara stated that these data showing the effectiveness and protection of the vaccine are positive. emergency use approval He stated that it was presented to the evaluating commission.

Dr. Ateş Kara, while examining the side effects as well as the effectiveness of the vaccine “As inactivated vaccines against the coronavirus are administered to approximately 3.5 billion people worldwide, we know what the potential adverse effects are. In this regard, we have an advantage over the beginning. also in TURKOVAC these effects We’re looking to see if it’s seen.” said. TURKOVAC’s data on side effects is positive observed.

RELATED NEWS

How Effective Third-Dose Vaccine Is Against Omicron Variant Explained

As a result of these comprehensive evaluations of the commission, emergency use approval was given to TURKOVAC. reliable in every way will prove it. In addition to the mRNA and Sinovac vaccines applied in our country after the vaccine was approved, a third vaccine It can also be used in TURKOVAC.

Source :
https://www.aa.com.tr/tr/koronavirus/bilim-kurulu-uyesi-prof-dr-kara-turkovac-uygulenen-kisideki-agir-hastalenen-or-hastaneye-yatan-olmadi/2451492


source site-33